| WKY |
plasma angiotensin II level |
controlled in utero environment (30 % of calories) (for 22 days) |
Riviere G, et al., Hypertension. 2005 Nov;46(5):1169-74. Epub 2005 Oct 3. |
blood angiotensin II amount |
male |
112.0 days
| 7 |
|
73.8 |
pg/ml |
12.7 |
33.6 |
immunoassay |
0.0 |
|
101690 |
2218 |
| WKY |
heart angiotensin I converting enzyme 2 activity level |
controlled in utero environment (100 % of calories) (for 22 days) |
Riviere G, et al., Hypertension. 2005 Nov;46(5):1169-74. Epub 2005 Oct 3. |
angiotensin I-converting enzyme activity |
male |
112.0 days
| 5 |
|
0.02 |
nmol/min/mg |
0.01 |
0.02 |
high-performance liquid chromatography |
0.0 |
|
99077 |
2218 |
| WKY |
plasma potassium level |
controlled in utero environment (30 % of calories) (for 22 days) |
Riviere G, et al., Hypertension. 2005 Nov;46(5):1169-74. Epub 2005 Oct 3. |
blood potassium amount |
male |
112.0 days
| 7 |
|
11.98 |
mmol/l |
1.12 |
2.96 |
inductively coupled plasma-atomic emission spectrometry |
0.0 |
|
99092 |
2218 |
| WKY |
plasma renin activity level |
controlled in utero environment (30 % of calories) (for 22 days) |
Riviere G, et al., Hypertension. 2005 Nov;46(5):1169-74. Epub 2005 Oct 3. |
renin activity |
male |
112.0 days
| 6 |
|
0.48 |
ng/ml/h |
0.08 |
0.2 |
enzyme or transport activity assay |
0.0 |
|
99098 |
2218 |
| WKY |
lung angiotensin I converting enzyme 2 activity level |
controlled in utero environment (30 % of calories) (for 22 days) |
Riviere G, et al., Hypertension. 2005 Nov;46(5):1169-74. Epub 2005 Oct 3. |
angiotensin I-converting enzyme activity |
male |
112.0 days
| 6 |
|
0.14 |
nmol/min/mg |
0.02 |
0.05 |
high-performance liquid chromatography |
0.0 |
|
99081 |
2218 |
| WKY |
kidney angiotensin I converting enzyme 2 activity level |
controlled in utero environment (30 % of calories) (for 22 days) |
Riviere G, et al., Hypertension. 2005 Nov;46(5):1169-74. Epub 2005 Oct 3. |
angiotensin I-converting enzyme activity |
male |
112.0 days
| 6 |
|
1.56 |
nmol/min/mg |
0.37 |
0.91 |
high-performance liquid chromatography |
0.0 |
|
99082 |
2218 |
| WKY |
mean arterial blood pressure |
controlled in utero environment (100 % of calories) (for 22 days) |
Riviere G, et al., Hypertension. 2005 Nov;46(5):1169-74. Epub 2005 Oct 3. |
arterial blood pressure trait |
male |
112.0 days
| 5 |
undefined |
66.0 |
mmHg |
2.0 |
4.47 |
tail cuff plethysmography |
0.0 |
|
101685 |
2218 |
| WKY |
plasma aldosterone level |
controlled in utero environment (100 % of calories) (for 22 days) |
Riviere G, et al., Hypertension. 2005 Nov;46(5):1169-74. Epub 2005 Oct 3. |
blood aldosterone amount |
male |
112.0 days
| 5 |
|
470.0 |
pg/ml |
8.0 |
17.89 |
radioimmunoassay |
0.0 |
|
101691 |
2218 |
| WKY |
plasma aldosterone level |
controlled in utero environment (30 % of calories) (for 22 days) |
Riviere G, et al., Hypertension. 2005 Nov;46(5):1169-74. Epub 2005 Oct 3. |
blood aldosterone amount |
male |
112.0 days
| 6 |
|
1130.0 |
pg/ml |
240.0 |
587.88 |
radioimmunoassay |
0.0 |
|
101692 |
2218 |
| WKY |
body weight |
controlled in utero environment (100 % of calories) (for 22 days) |
Riviere G, et al., Hypertension. 2005 Nov;46(5):1169-74. Epub 2005 Oct 3. |
body mass |
male |
112.0 days
| 17 |
|
454.0 |
g |
8.0 |
32.98 |
body weighing method |
0.0 |
|
99075 |
2218 |
| WKY |
plasma sodium level |
controlled in utero environment (100 % of calories) (for 22 days) |
Riviere G, et al., Hypertension. 2005 Nov;46(5):1169-74. Epub 2005 Oct 3. |
blood sodium amount |
male |
112.0 days
| 7 |
|
139.41 |
mmol/l |
4.17 |
11.03 |
inductively coupled plasma-atomic emission spectrometry |
0.0 |
|
99089 |
2218 |
| WKY |
plasma sodium level |
controlled in utero environment (30 % of calories) (for 22 days) |
Riviere G, et al., Hypertension. 2005 Nov;46(5):1169-74. Epub 2005 Oct 3. |
blood sodium amount |
male |
112.0 days
| 7 |
|
148.97 |
mmol/l |
4.08 |
10.79 |
inductively coupled plasma-atomic emission spectrometry |
0.0 |
|
99090 |
2218 |
| WKY |
urine sodium level |
controlled in utero environment (30 % of calories) (for 22 days) |
Riviere G, et al., Hypertension. 2005 Nov;46(5):1169-74. Epub 2005 Oct 3. |
urine sodium amount |
male |
112.0 days
| 7 |
|
55.41 |
mmol/l |
18.4 |
48.68 |
inductively coupled plasma-atomic emission spectrometry |
0.0 |
|
99094 |
2218 |
| WKY |
plasma renin activity level |
controlled in utero environment (100 % of calories) (for 22 days) |
Riviere G, et al., Hypertension. 2005 Nov;46(5):1169-74. Epub 2005 Oct 3. |
renin activity |
male |
112.0 days
| 5 |
|
0.43 |
ng/ml/h |
0.05 |
0.11 |
enzyme or transport activity assay |
0.0 |
|
99097 |
2218 |
| WKY |
kidney renin level |
controlled in utero environment (100 % of calories) (for 22 days) |
Riviere G, et al., Hypertension. 2005 Nov;46(5):1169-74. Epub 2005 Oct 3. |
kidney renin amount |
male |
112.0 days
| 5 |
|
136.5 |
ng/ml/h |
14.1 |
31.53 |
enzyme or transport activity assay |
0.0 |
|
99099 |
2218 |
| WKY |
lung angiotensin I converting enzyme 2 activity level |
controlled in utero environment (100 % of calories) (for 22 days) |
Riviere G, et al., Hypertension. 2005 Nov;46(5):1169-74. Epub 2005 Oct 3. |
angiotensin I-converting enzyme activity |
male |
112.0 days
| 5 |
|
0.07 |
nmol/min/mg |
0.02 |
0.04 |
high-performance liquid chromatography |
0.0 |
|
99078 |
2218 |
| WKY |
heart angiotensin I converting enzyme 2 activity level |
controlled in utero environment (30 % of calories) (for 22 days) |
Riviere G, et al., Hypertension. 2005 Nov;46(5):1169-74. Epub 2005 Oct 3. |
angiotensin I-converting enzyme activity |
male |
112.0 days
| 6 |
|
0.02 |
nmol/min/mg |
0.01 |
0.02 |
high-performance liquid chromatography |
0.0 |
|
99080 |
2218 |
| WKY |
kidney angiotensin I converting enzyme activity level |
controlled in utero environment (30 % of calories) (for 22 days) |
Riviere G, et al., Hypertension. 2005 Nov;46(5):1169-74. Epub 2005 Oct 3. |
angiotensin I-converting enzyme activity |
male |
112.0 days
| 6 |
|
0.39 |
nmol/min/mg |
0.08 |
0.2 |
high-performance liquid chromatography |
0.0 |
|
99088 |
2218 |
| WKY |
urine sodium level |
controlled in utero environment (100 % of calories) (for 22 days) |
Riviere G, et al., Hypertension. 2005 Nov;46(5):1169-74. Epub 2005 Oct 3. |
urine sodium amount |
male |
112.0 days
| 7 |
|
57.21 |
mmol/l |
17.0 |
44.98 |
inductively coupled plasma-atomic emission spectrometry |
0.0 |
|
99093 |
2218 |
| WKY |
urine potassium level |
controlled in utero environment (100 % of calories) (for 22 days) |
Riviere G, et al., Hypertension. 2005 Nov;46(5):1169-74. Epub 2005 Oct 3. |
urine potassium amount |
male |
112.0 days
| 7 |
|
122.72 |
mmol/l |
30.2 |
79.9 |
inductively coupled plasma-atomic emission spectrometry |
0.0 |
|
99095 |
2218 |
| WKY |
kidney renin level |
controlled in utero environment (30 % of calories) (for 22 days) |
Riviere G, et al., Hypertension. 2005 Nov;46(5):1169-74. Epub 2005 Oct 3. |
kidney renin amount |
male |
112.0 days
| 6 |
|
145.3 |
ng/ml/h |
11.1 |
27.19 |
enzyme or transport activity assay |
0.0 |
|
99100 |
2218 |
| WKY |
systolic blood pressure |
controlled in utero environment (30 % of calories) (for 22 days) |
Riviere G, et al., Hypertension. 2005 Nov;46(5):1169-74. Epub 2005 Oct 3. |
arterial blood pressure trait |
male |
112.0 days
| 6 |
undefined |
125.0 |
mmHg |
2.0 |
4.9 |
tail cuff plethysmography |
0.0 |
|
101684 |
2218 |
| WKY |
kidney angiotensin I converting enzyme activity level |
controlled in utero environment (100 % of calories) (for 22 days) |
Riviere G, et al., Hypertension. 2005 Nov;46(5):1169-74. Epub 2005 Oct 3. |
angiotensin I-converting enzyme activity |
male |
112.0 days
| 5 |
|
0.35 |
nmol/min/mg |
0.06 |
0.13 |
high-performance liquid chromatography |
0.0 |
|
99085 |
2218 |
| WKY |
lung angiotensin I converting enzyme activity level |
controlled in utero environment (30 % of calories) (for 22 days) |
Riviere G, et al., Hypertension. 2005 Nov;46(5):1169-74. Epub 2005 Oct 3. |
angiotensin I-converting enzyme activity |
male |
112.0 days
| 6 |
|
13.33 |
nmol/min/mg |
0.29 |
0.71 |
high-performance liquid chromatography |
0.0 |
|
99087 |
2218 |
| WKY |
kidney angiotensin I converting enzyme 2 activity level |
controlled in utero environment (100 % of calories) (for 22 days) |
Riviere G, et al., Hypertension. 2005 Nov;46(5):1169-74. Epub 2005 Oct 3. |
angiotensin I-converting enzyme activity |
male |
112.0 days
| 5 |
|
1.69 |
nmol/min/mg |
0.28 |
0.63 |
high-performance liquid chromatography |
0.0 |
|
99079 |
2218 |
| WKY |
heart angiotensin I converting enzyme activity level |
controlled in utero environment (100 % of calories) (for 22 days) |
Riviere G, et al., Hypertension. 2005 Nov;46(5):1169-74. Epub 2005 Oct 3. |
angiotensin I-converting enzyme activity |
male |
112.0 days
| 5 |
|
0.08 |
nmol/min/mg |
0.01 |
0.02 |
high-performance liquid chromatography |
0.0 |
|
99083 |
2218 |
| WKY |
systolic blood pressure |
controlled in utero environment (100 % of calories) (for 22 days) |
Riviere G, et al., Hypertension. 2005 Nov;46(5):1169-74. Epub 2005 Oct 3. |
arterial blood pressure trait |
male |
112.0 days
| 5 |
undefined |
104.0 |
mmHg |
2.0 |
4.47 |
tail cuff plethysmography |
0.0 |
|
101683 |
2218 |
| WKY |
mean arterial blood pressure |
controlled in utero environment (30 % of calories) (for 22 days) |
Riviere G, et al., Hypertension. 2005 Nov;46(5):1169-74. Epub 2005 Oct 3. |
arterial blood pressure trait |
male |
112.0 days
| 6 |
undefined |
79.0 |
mmHg |
2.0 |
4.9 |
tail cuff plethysmography |
0.0 |
|
101686 |
2218 |
| WKY |
plasma angiotensin II level |
controlled in utero environment (100 % of calories) (for 22 days) |
Riviere G, et al., Hypertension. 2005 Nov;46(5):1169-74. Epub 2005 Oct 3. |
blood angiotensin II amount |
male |
112.0 days
| 6 |
|
41.3 |
pg/ml |
11.5 |
28.17 |
immunoassay |
0.0 |
|
101689 |
2218 |
| WKY |
body weight |
controlled in utero environment (100 % of calories) (for 22 days) |
Riviere G, et al., Hypertension. 2005 Nov;46(5):1169-74. Epub 2005 Oct 3. |
body mass |
not specified |
1.0 days
| 26 |
|
6.64 |
g |
0.14 |
0.71 |
body weighing method |
0.0 |
|
99073 |
2218 |
| WKY |
heart angiotensin I converting enzyme activity level |
controlled in utero environment (30 % of calories) (for 22 days) |
Riviere G, et al., Hypertension. 2005 Nov;46(5):1169-74. Epub 2005 Oct 3. |
angiotensin I-converting enzyme activity |
male |
112.0 days
| 6 |
|
0.08 |
nmol/min/mg |
0.01 |
0.02 |
high-performance liquid chromatography |
0.0 |
|
99086 |
2218 |
| WKY |
plasma potassium level |
controlled in utero environment (100 % of calories) (for 22 days) |
Riviere G, et al., Hypertension. 2005 Nov;46(5):1169-74. Epub 2005 Oct 3. |
blood potassium amount |
male |
112.0 days
| 7 |
|
10.28 |
mmol/l |
0.41 |
1.08 |
inductively coupled plasma-atomic emission spectrometry |
0.0 |
|
99091 |
2218 |
| WKY |
urine potassium level |
controlled in utero environment (30 % of calories) (for 22 days) |
Riviere G, et al., Hypertension. 2005 Nov;46(5):1169-74. Epub 2005 Oct 3. |
urine potassium amount |
male |
112.0 days
| 7 |
|
112.58 |
mmol/l |
26.7 |
70.64 |
inductively coupled plasma-atomic emission spectrometry |
0.0 |
|
99096 |
2218 |
| WKY |
lung angiotensin I converting enzyme activity level |
controlled in utero environment (100 % of calories) (for 22 days) |
Riviere G, et al., Hypertension. 2005 Nov;46(5):1169-74. Epub 2005 Oct 3. |
angiotensin I-converting enzyme activity |
male |
112.0 days
| 5 |
|
9.05 |
nmol/min/mg |
1.46 |
3.26 |
high-performance liquid chromatography |
0.0 |
|
99084 |
2218 |